In addition, it has been well known for a long time that today ́s standard diagnostic repertoire such as exact morphometric measures, different parameters of ß-Amyloid and Tau quantification in CSF or in the living brain by the measure of PET can diagnose AD even before the onset of clinical symptoms (Bateman et al. 2012). This evidence concerns the gene MAPT and Alzheimer disease.